KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 118 filers reported holding KITE PHARMA INC in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,408,000 | +277.4% | 32,877 | +185.7% | 0.04% | +218.2% |
| Q1 2017 | $903,000 | +37.9% | 11,507 | -21.2% | 0.01% | +83.3% |
| Q4 2016 | $655,000 | +141.7% | 14,608 | +201.4% | 0.01% | +100.0% |
| Q3 2016 | $271,000 | -49.3% | 4,847 | -44.1% | 0.00% | -50.0% |
| Q4 2015 | $535,000 | -3.4% | 8,675 | -12.8% | 0.01% | -25.0% |
| Q3 2015 | $554,000 | +222.1% | 9,943 | +234.0% | 0.01% | +166.7% |
| Q4 2014 | $172,000 | – | 2,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|